Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cidara Therapeutics (CDTX) Change in Acquisitions & Divestments: 2017-2018

Historic Change in Acquisitions & Divestments for Cidara Therapeutics (CDTX) over the last 2 years, with Dec 2018 value amounting to $4.5 million.

  • Cidara Therapeutics' Change in Acquisitions & Divestments fell 10.00% to $4.5 million in Q4 2018 from the same period last year, while for Dec 2018 it was $29.0 million, marking a year-over-year change of. This contributed to the annual value of $29.0 million for FY2018, which is 19.45% up from last year.
  • Cidara Therapeutics' Change in Acquisitions & Divestments amounted to $4.5 million in Q4 2018, which was down 53.94% from $9.8 million recorded in Q3 2018.
  • Cidara Therapeutics' Change in Acquisitions & Divestments' 5-year high stood at $11.4 million during Q1 2017, with a 5-year trough of $4.5 million in Q4 2018.
  • In the last 2 years, Cidara Therapeutics' Change in Acquisitions & Divestments had a median value of $7.9 million in 2017 and averaged $7.6 million.
  • Over the last 5 years, Cidara Therapeutics' Change in Acquisitions & Divestments had its largest YoY gain of 7.23% in 2018, and its largest YoY loss of 44.87% in 2018.
  • Quarterly analysis of 2 years shows Cidara Therapeutics' Change in Acquisitions & Divestments stood at $5.0 million in 2017, then declined by 10.00% to $4.5 million in 2018.
  • Its Change in Acquisitions & Divestments was $4.5 million in Q4 2018, compared to $9.8 million in Q3 2018 and $8.5 million in Q2 2018.